semaglutide launch Dr. Reddy's Laboratories is gearing up to its generic injection in March, reportedly under the brand name #Obeda, as patent protection expires in 2025, according to Reuters. Semaglutide, the key India GLP-1 Market Shift: Mankind
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

























